Text Size

The Impact of Vitamin D on Tuberculosis Among Koreans

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by Seoul National University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01137370
First received: June 3, 2010
Last updated: NA
Last verified: June 2010
History: No changes posted
  Purpose

Vitamin D has been regarded to be beneficial to tuberculosis (TB) patients. The aim of this study is to elucidate the role of vitamin D deficiency in development and treatment outcomes among Korean TB patients. Furthermore, the impact of genotypes of vitamin D receptor gene on TB development will also be evaluated.


Condition
Tuberculosis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Impact of Vitamin D Level and Single Nucleotide Polymorphisms of Vitamin D Receptor Gene on the Development and Treatment Response of Tuberculosis

Resource links provided by NLM:

Drug Information available for: Vitamin D
U.S. FDA Resources

Further study details as provided by Seoul National University Hospital:

Biospecimen Retention:   Samples With DNA

Serums for vitamin D measurement DNA for genotyping of vitamin D receptor gene


Estimated Enrollment: 298
Study Start Date: January 2010
Estimated Study Completion Date: March 2011
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Patients with TB
People without TB

  Eligibility

Ages Eligible for Study:   20 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Patients diagnosed and treated as having a TB in Seoul National University Hospital

Criteria

Inclusion Criteria:

  • older than 19 years
  • diagnosed and treated having a tuberculosis

Exclusion Criteria:

  • positive HIV antibody
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01137370

Locations
Korea, Republic of
Seoul National University Hospital Recruiting
Seoul, Korea, Republic of, 110-744
Contact: Jae-Joon Yim, MD     82-2-2072-2059     yimjj@snu.ac.kr    
Principal Investigator: Jae-Joon Yim, MD            
Sponsors and Collaborators
Seoul National University Hospital
  More Information

No publications provided

Responsible Party: Jae-Joon Yim / Associate Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT01137370     History of Changes
Other Study ID Numbers: H-0911-066-301
Study First Received: June 3, 2010
Last Updated: June 3, 2010
Health Authority: South Korea: Institutional Review Board

Additional relevant MeSH terms:
Tuberculosis
Mycobacterium Infections
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections
Vitamin D
 Vitamins
Bone Density Conservation Agents
Physiological Effects of Drugs
Pharmacologic Actions
Micronutrients
Growth Substances

ClinicalTrials.gov processed this record on May 22, 2013